A5001: ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED TRIAL

A5001：成人艾滋病临床试验团体纵向连锁随机试验

• 批准号: 7604178
• 负责人: ROY M. GULICK
• 金额: $ 4.11万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7604178
• 关键词: AIDS clinical trial group; Adult; Clinical; Clinical Trials Cooperative Group; Computer Retrieval of Information on Scientific Projects Database; Detection; Failure; Funding; Grant; HIV-1; Immunologics; Institution; Link; Outcome; Protocols documentation; Randomized Controlled Clinical Trials; Research; Research Personnel; Resources; Source; United States National Institutes of Health; antiretroviral therapy; success

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary aim of the ALLRT (AIDS Clinical Trials Group Study 5001) multicenter protocol is to determine the long-term (4 years or longer) virologic, immunologic, and clinical outcomes and complications associated with the success or failure of prolonged use of potent antiretroviral therapies to achieve or maintain durable suppression of HIV-1 replication to levels below the limit of detection.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 ALLRT（艾​​滋病临床试验组研究 5001）多中心方案的主要目的是确定与长期使用强效抗逆转录病毒药物的成功或失败相关的长期（4 年或更长）病毒学、免疫学和临床结果以及并发症。实现或维持持久抑制 HIV-1 复制至低于检测限的水平的疗法。